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! INTRODUCTION
J oint prosthesis is a common and successfulprocedure with more than 800,000 implantsper year in the United States of America. Joint
prosthesis infection is a potentially devastating
and expensive complication and it has been
shown to develop after up to 2% of uncomplicat-
ed arthroplasties, while studies have reported an
incidence as high as 12.4% in certain patient pop-
ulations [1-5].
Distinguish joint arthroplasties with infection
from those without still presents a diagnostic
challenge, as none of the tests commonly used to
diagnose infection appear to be 100% sensitive
or specific when applied to patients who have
had a joint prosthesis. 
The acute infection usually shows, in fact, some
characteristic clinical and laboratory features,
whereas the diagnosis of the relatively frequent
subacute or low grade chronic infections is much
more problematic. Clinical examinations, labora-
tory studies, radiographs, nuclear scans, joint as-
pirations and histological frozen section analysis
all have notable rates of false positive and false
negative results [6-10]. 
Misdiagnosis of joint prosthesis infection may
delay proper intervention or may lead to inap-
propriate treatment. Aseptic prosthetic loosen-
ing may in fact be treated with one stage revi-
sion operation, while infection is the most
feared complication of total joint surgery as it
threatens the function of the joint, limb preser-
vation and occasionally even the life of the pa-
tient, requiring a suitable and much more com-
plex medico-surgical treatment [11]. 
To reduce the risk of misdiagnosis, in the clini-
cal setting multiple different diagnostic tests
are then usually performed in a staged process
and the final diagnosis comes from their com-
bined evaluation. 
While more and more sophisticated (and ex-
pensive) diagnostic procedures are proposed to
make more reliable the diagnosis of septic com-
plication in joint prosthesis, the choice and the
evaluation of the various tests to be performed
in a given patient still depends largely on a sub-
jective evaluation process of the physician and
on logistical and/or cost restrictions of different
centers. 
The aim of this study is to propose and prospec-
tively evaluate the efficacy of a new automatic
calculation tool of multiple independent diag-
nostic tests, compared to the “gold” standard of
the intra-operative tests, in an effort to provide
an objective and reproducible instrument for
the evaluation of the overall and relative contri-
bution of each exam to the final diagnostic out-
put. While the proposed calculation tool, for the
purpose of this study, has been applied to the
differential diagnosis of painful joint prosthe-
sis, it appears potentially useful in other clinical
conditions that require multiple combined in-
dependent diagnostic testing.
! METHODS
“Combined Diagnostic Tool” rationale
When we perform a series of independent tests
in a given subject in the suspect of a given dis-
ease, we may observe some positive and some
other negative tests. What is the respective con-
tribution of positive and negative tests to the fi-
nal diagnostic output and, in case of conflicting
results, how do we compare positive and nega-
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tive results? Specificity of a test measures the
proportion of True Negatives (TN) and False
Positives (FP), according to the formula:
TN/(TN+FP). A test with a specificity of 0.8 will
be able to correctly exclude the disease in 80% of
the subjects (TN), while the remaining 20% will
be FP. Sensitivity measures the proportion of ac-
tual positives which are correctly identified as
such (True Positives, TP) and the number of
False Negatives (FN). Sensitivity is in fact ex-
pressed by the formula: TP/(TP+FN). If a given
test has a sensitivity of 0.7, it will correctly de-
tect the disease in 70% of the patients (TP) and it
will not in the remaining 30% (FN). In a given
subject, a positive or negative test, will have, re-
spectively, the following chances of being:
TN = specificity of the negative test
FN = 1 - sensitivity of the negative test
TP = sensitivity of the positive test
FP = 1 - specificity of the positive test
Consider a test with a specificity and sensitivity
of, respectively, 0.8 and 0.7. If that test is negative
in a subject, he will have 80% (specificity of the
negative test) chance of being a TN and 30% (1 -
sensitivity of the negative test) of being a FN.
The relative proportion of TN and FN of a neg-
ative test, will be called Negative Test Index
(NTI), and is calculated according to the for-
mula: 
NTI = TN/FN = specificity of the negative
test/1 - sensitivity of the negative test
NTI indicates the relative chances that the sub-
ject, seen as negative by a given test, has to be
TN compared to FN. The higher the value of
NTI, the higher the chance that test correctly in-
dicated that subject as NOT having the disease.
In the example: NTI = TN/FN = 80/30 = 2.66.
The chance that this negative test correctly indi-
cated the subject as NOT infected is 2.66 times
the chances that it gave a falsely negative result.
Following the example, if the same test is posi-
tive in a subject, he will have 70% (sensitivity of
the positive test) chance of being a TP and 20%
(1 - specificity of the positive test) of being a FP.
The ratio between the chance of being a TP and
that of being a FP will be called in this study
Positive Test Index (PTI):
PTI = TP/FP = sensitivity of the positive test/
1 - specificity of the positive test
PTI indicates the relative chance that the subject
is a TP compared to a FP. The higher the value
of PTI, the higher the chance that test correctly
indicated that subject as HAVING the disease.
In the example: PTI = TP/FP = 70/20 = 3.50.
The chance that this positive test correctly indi-
cated the subject as INFECTED is 3.50 times the
chances that it gave a falsely positive result.
If we have n independent tests, performed on a
same subject, the combined chance of positive
or negative results to be true is, respectively,
the following:
PTIn=TPa * TPb * TPn/FPa * FPb * FPn =
NTIn=TNa * TNb * TNn/FNa * FNb * FNn =
The ratio between PTI and NTI will be indicat-
ed as the Combined Tests Index (CTI):
CTI = PTIn/NTIn
CTI expresses how many times the output of
the combined positive tests is, compared to the
output of the combined negative tests. The
higher its value, the higher the chance the posi-
tive results are “more true” and that the subject
HAS the disease and viceversa.
The “Combined Diagnostic Tool” (CDT), for di-
agnosing septic complications in joint prosthe-
sis, is a software in which the reference values
of sensitivity and specificity of the most com-
mon diagnostic tests of infection of joint pros-
thesis have been implemented. Based on these
reference values and on the results of different
tests in a given subject, the software is able to
automatically calculate the NTI, PTI and CTI of
that subject (Table 1). Values of CTI >1 are in fa-
vor of infection. Values of CTI <1 are in favor of
an aseptic painful prosthesis. The software also
allows to assess the relative contribution of any
additional test and, in this way, it permits to ob-
jectively evaluate the relative cost/benefit of
any additional diagnostic procedure.
Bibliographic research
For the Combined Diagnostic Tool to work
properly in the clinical setting, it is mandatory to
accurately define the respective sensitivity and
specificity of each diagnostic test that is included
in the diagnostic process for a given disease. To
this aim, Medline and Embase research of pub-
lished papers from 1990 to 2008, concerning the
relative efficacy of different diagnostic proce-
dures commonly used for differential diagnosis
of painful joint prosthesis has been performed.
When more values of sensitivity or specificity for
a given test were available, their mean value has
been used for the Combined Diagnostic Tool.
Clinical application
The Combined Diagnostic Tool has been
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prospectively evaluated in a consecutive series
of 36 patients, affected by a painful joint pros-
thesis, that presented to our observation in
years 2007-2008.
Each patient underwent multiple diagnostic
tests to exclude or confirm the suspect of infec-
tion. The choice of the diagnostic tests was
based on the diagnostic process currently in use
at our institution. This include first line tests:
clinical examination, laboratory testing (ery-
thro-sedimentation rate, ESR, C-reactive pro-
tein, CRP) and plain x-ray examination; then a
choice of second line tests: sonography, joint as-
piration (cultural examination and white cell
blood count, WBC), 99Technetium bone scan; in
selected cases third line tests were performed:
leucocyte bone scan, positron emission tomog-
raphy (PET), computer tomography (CT) scan. 
Pre-operative tests results were collected by a
dedicated investigator, to assess the NTI, PTI
and CTI of each patient with the Combined Di-
agnostic Tool. Based on these pre-operative
tests and, in selected cases, on the additional
testing of intra-operative frozen sections, all the
patients underwent surgical intervention and
one- or two-stage revision of the prosthesis. 
At intervention, histological and cultural exam-
inations were performed from two indepen-
dent investigators, not aware of the results of
the Combined Diagnostic Tool. The results of
the intra-operative tests were then compared to
the output of pre-operative tests, using the
Combined Diagnostic Tool. Intra-operative cul-
tural sampling was performed as it follows. At
least three periprosthetic samples from differ-
ent sites were submitted to the laboratory for
culture. Liquid samples that were aspirated
from the operative site with use of a sterile sy-
ringe were immediately inoculated into Bactec
9000 Blood Culture Systems (Becton Dickinson
Diagnostic Instruments, Sparks, Maryland) and
were incubated for seven days. Positive flasks
were subcultured in aerobic and anaerobic agar
media. Swab samples were obtained by passing
a sterile swab over the area of tissue, bone, or
fluid that was suspected of being infected. Sol-
id tissue samples from pseudocapsule, the
membrane around the prosthesis or tissue that
was suspected to be infected were immediately
placed into a separate sterile universal bottle.
Solid tissue samples and swab samples were
cultured in aerobic and anaerobic agar media
and in thioglycolate broth enriched with vita-
min K and hemin and were incubated for ten
days. Positive cultures were sent for organism
identification and sensitivity testing.
Samples for frozen-section analysis and perma-
nent histological analysis were obtained from
the pseudocapsule, the membrane around the
prosthesis, or tissue that was suspected to be in-
fected. Each of two samples from each patient
were divided into two parts, one for frozen-sec-
tion analysis and one for permanent paraffin-
embedded section analysis. The samples that
were used for frozen-section analysis were
snap-frozen in carbon dioxide; 4- m sections
were then cut and stained with hematoxylin and
eosin. The samples used for histological analysis
of paraffin-embedded sections were fixed in for-
malin and embedded in paraffin prior to stain-
ing with hematoxylin and eosin. The most cellu-
lar areas in the tissue sample were chosen for
evaluation, and the number of neutrophils (in
the frozen and paraffin-embedded sections),
lymphocytes, and plasma cells (in the paraffin-
embedded sections) per high-power field (×400)
in at least ten separate microscopic fields were
counted. The histological Feldman criterion, de-
fined as the presence of at least five neutrophils
per high-power field (×400) in at least five sepa-
Table 1 - Combined Diagnostic Tool (CDT) software. In the example below: Positive Tests Index (PTI) = 35.55.
Combined positive tests have 35.55 chance of seeing the subject under study as a True Positive (TP), compa-
red to 1 chance that he/she is a False Positive (FP); Negative Tests Index (NTI) = 4050. Negative tests have 4050
chances of seeing the subject under study as a True Negative (TN), compared to 1 chance that he/she is a Fal-
se Negative (FN); the Combined tests Index (CTI) is then 0.008, or the relative chances that the subject has an
infected prosthesis are 8:1000. The subject is to be considered not infected.
Test A Test B Test C Test N
Positive TP (sensitivity of the positive test)/ 0.91 0.93
PTI 35.55
tests FP (1 - specificity of the positive test) 0.14 0.17
CTI 0.0087
Negative TN (specificity of the negative test)/ 0.81 0.9
NTI 4050.0
tests FN (1 - sensitivity of the negative test) 0.18 0.001
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Table 2 - Reference values of sensitivity, specificity used in the Combined Diagnostic Tool (bibliographic re-
ferences in brackets).
Test Reference values used for calculations
Sensitivity 0,84
C-reactive Protein [2, 14-17] Specificity 0,87
Sensitivity 0,78
Erythrosedimentation rate [2, 6, 15] Specificity 0,78
Sensitivity 0,98
Serum interleukin-6 [14, 18] Specificity 0,91
Sensitivity 0,33
Procalcitonin [14] Specificity 0,98
Sensitivity 0,43
TNF-alpha [14] Specificity 0,94
Sensitivity 0,29
White-blood cell count [17, 19] Specificity 0,94
Sensitivity 0,79
Plain X-ray [20, 21] Specificity 0,55
Sensitivity 0,75
Helical CT (Bone) [21] Specificity 0,30
Sensitivity 1,00
Helical CT (Soft Tissues) [21] Specificity 0,87
Sensitivity 1,00
Sonography [22] Specificity 0,77
Sensitivity 0,69
Three Phase Bone scan [6, 20, 23] Specificity 0,83
Sensitivity 0,62
Leukocite Bone scan [17, 24] Specificity 0,88
Sensitivity 0,85
FDG-PET [25] Specificity 0,93
Sensitivity 0,28
Pyrexia (5 days post-op) [26] Specificity 0,62
Sensitivity 0,97
Histology [16, 19] Specificity 0,96
Sensitivity 0,45
Histology (frozen section) [2, 27, 28] Specificity 0,96
Sensitivity 0,86
Intra-operative coltures [2, 19] Specificity 0,95
Sensitivity 0,69
Joint aspiration (coltural examination) Specificity 0,84
[2, 6, 16, 17, 19, 29, 30] Sensitivity 0,33
Joint aspiration (white blood cell) [2] Specificity 0,99
Sensitivity 0,89
Joint aspiration (Neutrophils >80%) [2] Specificity 0,85
rate microscopic fields was used [9, 12, 13].
For comparison purposes, pre-surgical tests
outcome, obtained by means of the Combined
Diagnostic Tool, has been compared to intra-
operative results. A patient was considered to
be infected if either one of the following condi-
tions applied:
- positive intra-operative cultural examination;
- positive permanent histological finding.
The present study was considered double-
blinded in the sense that the results of pre-op-
erative tests, used to perform calculations with
the Combined Diagnostic Tool, were collected
by one of the investigator before the intra-oper-
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ative results were given and the investigators
that performed the intra-operative histological
and cultural examinations were not aware of
pre-operative results. 
Statistical analysis has been performed with the
unpaired Student’s t test. The level of signifi-
cance was set at p<0.05.
! RESULTS
Data regarding respective sensitivity and
specificity of different diagnostic tests, used in
the Combined Diagnostic Tool, are summa-
rized in Table 2. The literature review confirms
the lack of a single test that is 100% specific and
S THR 0,2 - + - + + 63,876 7,235 8,829
S THR 2,0 - + - - + + - + + 13275,97 49,84 266,388
S THR 2,0 + + + - 99,48 2,54 39,243
S THR 3,0 + + - + + 465,73 1,32 353,630
S THR 1,0 + + - - + - + - 173311,23 5397,63 32,109
S THR 1,0 + + + - - - - + - + + 217182,14 1674,38 129,709
S THR 1,5 + - - + + - - - + + 4367,38 37,68 115,907
S THR 1,0 + + - + - - + + 18791,00 7,59 2476,737
S THR 1,5 + + - - - + + - - - 3018,89 272,47 11,080
S THR 3,0 + + - + + + 1820,97 1,32 1382,667
S THR 3,0 - + - + - - + + 10370,59 48,24 214,970
S TKR 2,5 + - - - - + - + + 6144,92 130,32 47,154
S TKR 0,6 + - - - + + + + 20904,71 11,94 1751,253
S TKR 1,0 + - - - + + - + + 24226,51 32,44 746,787
S TKR 1,0 + + - - + + + 18534,59 3,34 5552,605
S TKR 1,0 + + - - + 87,908 3,34 26,336
S TKR 4,0 + + - + - + + + + - - 248602,86 2934,87 84,707
S TKR 4,0 + + + - - + 3282,85 6,89 476,534
S TKR 2,0 - + + + + + - + 17223,07 14,93 1153,665
S TKR 6,0 + + - - - + 248,61 8,78 28,315
S TER 6,0 + - - + + - 151,67 3,58 42,376
Performed tests 21 21 21 6 1 19 2 13 9 1 5 17 12 10
% Positive Tests 0,81 0,76 0,19 0,83 1,00 0,16 0,00 0,54 0,90 1,00 1,00 0,47 0,83 0,70
MEAN 2.0 37246,43 507,17 711,48
SD 2.0 74918,75 1327,57 1298,42
*S THR - S TKR - S TER: respectively, septic total hip, knee and elbow replacement. **CT: computed tomography. ***FDG - PET: Fluoro-
deoxyglucose-Positron Emission Tomography. ****WBC: White cells count
Table 3 - Data from patients with final diagnosis of septic joint prosthesis (N=21).
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sensitive for diagnosing joint prosthesis infec-
tion. Most of the good quality retrieved papers
regard laboratory tests [2, 6, 14-19] and imag-
ing techniques [6, 17, 20-25] even if data con-
cerning traditional radiological exams (plain x-
ray and sonography) look remarkably poor
and from limited series of patients. 
We also could not find any published data on
sensitivity and specificity of clinical signs and
symptoms (only one study [26] concerns the
occurrence of pyrexia in the immediate post-
operative period). 
The remaining good quality studies are fo-
cused on invasive procedures like joint aspira-
tion [2, 6, 16, 17, 19, 29, 30], histology [2, 27, 28]
and intra-operative coltures [2, 19]. Other im-
portant limitations, regarding the reliability of
reference values of diagnostic tests, that
emerge from the present review of the litera-
ture, are reported in the Discussion chapter.
Analytical results from pre-operative diagnos-
tic test from the 36 patients are reported in Ta-
bles 3 and 4. 
21 patients were diagnosed as affected by a sep-
tic joint prosthesis on the basis of intra-operative
findings (intra-operative cultural and/or per-
manent histological findings): 11 septic total hip
prosthesis, 9 septic total knee prosthesis, 1 sep-
tic elbow prosthesis. The remaining 15 patients
were diagnosed on the same basis, to have an
146
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A THR 2,0 - + - - - + + - - - 67,80 239,97 0,283
A THR 3,0 - - - + - + + - - - 52,27 1204,14 0,043
A THR 4,0 - + - - - + + + - - 25,475 191465,145 0,00013
A THR 1,5 + + - - + - + 454,78 3837,42 0,119
A THR 4,0 + + - - - + + + - - 162,50 34851,95 0,005
A THR 5,0 - + - + - - - 15,05 109,64 0,137
A THR 4,5 - + - - + + + + - - - - 890,848 30045,852 0,030
A THR 1,0 - - - - - + + 19,397 5049,713 0,004
A THR 4,0 - - + - + - - 7,697 9043,84 0,001
A THR 1,5 - + - - - - + - 17,198 6457,012 0,003
A TKR 6,0 - - - + + + - - - 82,595 802,748 0,103
A TKR 1,0 - + - + - - - 3,50 569,03 0,006
A TKR 2,0 - - + - + - - - - 17,59 3511,81 0,005
A TKR 3,0 + - - + + - - - 43,388 146,122 0,297
A TKR 2,0 + - - - - - 6,38 85,34 0,075
Performed tests 15 15 15 8 3 15 3 14 10 2 6 8 7 5
% Negative Tests 0,73 0,47 0,87 0,75 0,67 0,53 0,33 0,29 0,60 0,00 1,00 1,00 0,86 1,00
MEAN 2.9 124,431 19161,315 0,074
SD 1.5 240,921 48878,517 0,099
*A THR - A TKR: respectively, aseptic hip and knee replacement. **CT: computed tomography. ***FDG - PET: Fluorodeoxyglucose-Posi-
tron Emission Tomography. ****WBC: White cells count.
Table 4 - Data from patients with final diagnosis of aseptic joint prosthesis (N=15).
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aseptic loosened of painful hip (10 cases) or
knee prosthesis (5 patients). Male/female, age
and time from prosthetic implant were: 8/13,
59±10 and 2.0±2.1, for infected cases and 4/11,
63±8 and 2.9±1.5 for not infected cases. 
All of the infected patients had a CTI >1 (range:
from 8.8 to 5552.6), while all of the 15 patients
who had negative intra-operative results for in-
fection, had a CTI <1 (range: from 0.00013 to
0.297) (Figure 1). 
Overall Positive Tests Index was higher in in-
fected cases (37246±74918) compared to non in-
fected prosthesis (124±240), but not quite statis-
tically significant (p=0.06). In a reverse manner,
Negative Tests Index was higher in non infect-
ed patients compared to infected cases
(19161±48878 versus 507±1327), but the differ-
ence was still not statistically significant
(p=0.08). In non infected prosthesis, the NTI
was lower than PTI (124±240 versus
1916±48878), but the difference was not statisti-
cally significant (p=0.14). 
These values probably reflect the high standard
deviations, due to the heterogeneous series of
tests performed in each case and the relatively
limited number of patients included in the
study.
On the contrary, in infected prosthesis, the PTI
was shown to be significantly higher than NTI
(p=0.03) (37246±74918 versus 507±1327) and
the Combined Tests Index showed a significant
(p=0.04) difference between the two groups of
patients: 711.48±1298.42 in infected, compared
to 0.074+-0.099 in non-infected cases.
! DISCUSSION
In failed arthroplasties the distinction between
aseptic loosening and infection is important for
the prognosis and the choice of surgical and
medical management. Misdiagnosis may in fact
lead to delayed of wrong treatment.
Bibliographic research points out the lack a
100% sensitivity and specificity of a single test
for differential diagnosis between aseptic and
septic painful or loosened prosthesis and pro-
vides the basis for the currently used clinical
approach of multiple diagnostic testing. It also
shows the following main limitations of an ef-
fort to provide a single fixed value of sensitivi-
ty and specificity of a given test to diagnose
joint prosthesis infection:
- there is an objective lack of high quality pa-
pers, especially for traditional radiology and
for physical examination. We tried, whenever
possible, to refer to high-level meta-analysis
or to prospective evidence-based level I pa-
pers to find the most reliable data, but our
findings show that some of the most current-
Combined Tests Index (CTI) N=36
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Figure 1 - (Note that y axis is in logarithmic scale) Combined Tests Index (N=36). (S THR - S TKR - S TER: re-
spectively, septic total hip, knee and elbow replacement; A THR - A TKR: respectively, aseptic hip and knee re-
placement; TJR: total joint replacement). Mean values are statistically different (p=0.04).
ly used diagnostic tests (e.g. sonography) are
probably not adequately studied and avail-
able data are based on isolated studies on
limited series of patients.
- Reference normal values of a given diagnos-
tic test may differ among Authors. 
- Populations studied for validation of the
same or different tests may vary in different
studies.
- Inter-observer variability and different diag-
nostic criteria are a possible source of bias,
especially for imaging techniques and histo-
logical examination.
- When more than one study is found, sensi-
tivity and specificity values for a same test
may vary among different Authors. When
this occurred (e.g. for C-reactive protein val-
ues), for the purpose of this study the mean
value of the sensitivities and specificities re-
ported by the different studies has been cal-
culated and used as a reference value for the
Combined Diagnostic Tool; the reader
should be aware that this procedure may in-
troduce a bias, since not necessarily all stud-
ies are perfectly comparable. However the
other option, to choose one single study as
reference, may also appear not adequate to
correctly represent the overall experience of
different centers.
- Some studies may not have been retrieved in
the present analysis.
It should be pointed out that all the above men-
tioned limitations do also apply every time we
interpret the diagnostic findings in a given pa-
tient, on a subjective basis. This limits appear,
in fact, intrinsic to our current scientific knowl-
edge in the field, even if in a more empiric di-
agnostic process they are not always clearly
quantified. 
For this reason, in our opinion, these limita-
tions do not prevent the use of a calculation
tool like that proposed, once the bibliographic
sources and limits of research have been made
clear to the possible user. 
In should also be noted that bibliographic re-
search of reference values is a work-in-
progress and the Combined Diagnostic Tool is
thought may be periodically updated accord-
ing to any relevant new literature data.
In this study, intra-operative findings have
been considered as the golden standard in the
diagnosis of infected prosthesis, but it is worth
noting that both intra-operative cultural exam-
ination and histological findings are prone to
errors. As we may observe in Table 2, histology
has been reported to have a sensitivity of 1 or
0.94 and a specificity of 0.98 and 0.94, while in-
tra-operative cultural examination values
range from 0.78 to 0.94 for sensitivity and from
0.92 to 0.97 for specificity. 
Should we apply the Combined Diagnostic
Tool to this tests, we would see that intra-oper-
ative cultural examination and histology, when
positive in a subject, have a Positive Test Index
of, respectively, 17.2 and 24.2, when used alone
and a remarkable Positive Tests Index of 417,
when combined. 
In other words, if in a patient both of these tests
are found positive, he/she will have 417
chance versus 1 that that positive results are
true and that he/she is really infected. 
For comparison, the combination of C-reactive
protein and erythrosedimentation rate, consid-
ered one of the most powerful diagnostic com-
bination of prosthetic infections [2], has a PTI
of “only” 22.9. 
The main drawback of intra-operative findings
(except frozen sections) is that they provide the
required answer only days after the surgical in-
tervention, when the decision on the treatment
had been already necessarily done. The Com-
bined Diagnostic Tool, instead, appears to pro-
vide a pre-operative assessment of the risk of
infection that is comparable to that obtained
with the intra-operative findings, but that it
may be used in the pre-operative decision
making process. 
It also allow to quantify the relative contribu-
tion of each diagnostic test to the final diagnos-
tic output and this could be used for simulation
and to estimate the relative cost to benefit ratio
of different diagnostic procedures. 
Validation of the Combined Diagnostic Tool in
a larger series of patients in this and in other
challenging diagnostic clinical settings and col-
lection of data regarding the cost/benefit val-
ues of diagnostic tests is the object of currently
ongoing research.
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While diagnosing infection of a joint prosthesis of-
ten requires a multi-modal approach, evaluation of
combined multiple diagnostics is still a rather sub-
jective process. Based on the known sensitivity
and specificity of commonly performed tests for
joint prosthesis infection, we developed the Com-
bined Diagnostic Tool, a software program that
automatically allows the Combined Tests Index
(CTI) to be calculated. The CTI indicates, in a giv-
en subject, the relative probability of a combined
series of positive tests being true compared to neg-
ative tests. CTI values above 1 indicate a progres-
sively higher chance of a prosthesis being infected
and vice versa. Double-blind, prospective evalua-
tion of CTI, compared to intra-operative cultural
and histological findings, was performed in a con-
secutive cohort of 36 patients. 21 patients had pos-
itive intra-operative findings for infection. All of
them had a pre-operative CTI >1 (range: 8.8 to
5552.6; mean: 711±1298). 15 patients had negative
intra-operative results. All had a CTI <1 (range:
0.00013-0.297; mean 0.074±0.099). The difference in
CTI between the two groups was statistically sig-
nificant (p=0.04). Our results show that the Com-
bined Tests Index may be a useful indicator for dif-
ferential diagnosis of prosthetic infection.
SUMMARY
Mentre la diagnosi di infezione nelle protesi articolari
richiede spesso un approccio multi-modale, la valutazio-
ne di tests diagnostici combinati è ancora un processo
soggettivo. Utilizzando i dati di sensibilità e specificità
dei tests diagnostici comunemente eseguiti per la dia-
gnosi di infezione protesica, abbiamo sviluppato il Com-
bined Diagnostic Tool, un programma che calcola auto-
maticamente il Combined Tests Index (CTI); il CTI in-
dica, nel singolo soggetto, le possibilità di essere vera di
una combinazione di tests diagnostici positivi, compa-
rati con i tests negativi. Un CTI >1 indica una possibi-
lità progressivamente maggiore di una protesi di essere
infetta e viceversa.
L’indice CTI è stato valutato in uno studio prospettico,
in doppio cieco, in comparazione con l’esame colturale
ed istologico intra-operatorio, in una coorte consecutiva
di 36 pazienti. Ventuno pazienti avevano dati intra-ope-
ratori positivi per infezione. In tutti questi casi, si è os-
servato un CTI >1 (minimo: 8,8; massimo 5552,6; me-
dia: 711±1298). Quindici pazienti avevano dati intra-
operatori negativi. Tutti questi pazienti hanno mostra-
to un CTI <1 (0,00013-0,297; media 0,074±0,099). La
differenza di CTI nei due gruppi era statisticamente si-
gnificativa (p=0,04).
Il Combined Tests Index appare utile nella diagnosi dif-
ferenziale di infezione di protesi articolari.
RIASSUNTO
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